
OLD Category: Oncology
March 1, 2019 / Cancer Prev Res (Phila)
Sulforaphane Suppresses the Growth of Triple-negative Breast Cancer Stem-like Cells In vitro and In vivo
March 1, 2019 / Journal of Molecular Diagnostics
Design, Optimization, and Multisite Evaluation of a Targeted Next-Generation Sequencing Assay System for Chimeric RNAs from Gene Fusions and Exon-Skipping Events in Non–Small Cell Lung Cancer
March 1, 2019 / Clin Cancer Res
Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as Monotherapy
March 1, 2019 / Nat Med.
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
February 27, 2019 / Res Rep Urol.
Circulating blood miRNAs for prostate cancer risk stratification: miRroring the underlying tumor biology with liquid biopsies
February 26, 2019 / Blood Adv.
PD-L1 and tumor-associated macrophages in de novo DLBCL
February 26, 2019 / Int J Cancer.
Rogaratinib: A potent and selective pan-FGFR inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models
February 26, 2019 / Clin Cancer Res
Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials
February 25, 2019 / Nat Med
A Single Dose of Neoadjuvant PD-1 Blockade Predicts Clinical Outcomes in Resectable Melanoma
February 23, 2019 / Ann Oncol.